Tinley's Signs with BevCanna to Produce its Award-Winning Carbonated Tonics in Canada

The Tinley Beverage Company Inc. (CSE:TNY, OTC:TNYBF) ("Tinley's") is pleased to announce it has signed an agreement ("Agreement") with BevCanna Enterprises ("BevCanna") (collectively the "Companies") to produce Tinleys™ Classics, the Canadian versions of Tinley's award-winning, California-produced "Tinley's™ Tonics" cannabis beverages. Tinley's other product family, "Tinleys™ ‘27", will continue to be produced at Peak Processing Solutions ("Peak") in Ontario. The Company is also pleased to report updates on the much-anticipated production at Peak.

Agreement With BevCanna to Produce "Tinleys™ Classics" Cannabis Beverages in Canada

BevCanna will produce and distribute the full line of Tinley's ready-to-drink, adult beverage-inspired sparkling Tinleys Classics, Canadian versions of Tinley's Tonics, currently available in California. The line includes the Moscow Mule-inspired Tinley's™ Tonics High Horse™, winner of First Place at California's prestigious Emerald Cup, the world's largest cannabis competition. BevCanna will also produce Tinley's blue agave & lime-inspired Stone Daisy, the juniper berry & lime-inspired Juniper Sky and the blue agave, grapefruit & lime-inspired Mystic Dove. The beverages will be modified slightly for the Canadian market to reflect Canadian consumer tastes, formulations, packaging, and regulatory requirements. As in California, the award-winning beverages will be offered in 12 fl. oz bottles, each containing a micro-dose of THC to provide a light effect comparable to a single adult beverage. Made with premium botanicals and non-alcoholic flavors often found in national-brand spirits, along with non-cannabis-derived botanical terpenes blended to match the Pineapple Jack strain, the beverages are vegan and gluten-free. They're also crafted with Vertosa cannabis emulsion technology, combined with Tinley's unique terpene infusion methodology, which together are designed to accelerate on-set and provide a full-flower, euphoric effect reminiscent of the Pineapple Jacks sativa strain.

Tinley's is employing BevCanna's white-label partnership model for its Canadian production and distribution. The model allows non-licensed partners to enter the Canadian cannabis market seamlessly and in a compliant manner. Tinley's will leverage BevCanna's extensive experience in producing beverages at scale, as well as its Sales License partnership for distribution to provincial buying groups. Tinley's has committed to annual MOQs (minimum order quantities) as part of this white-label agreement. BevCanna is now in full commercial production, with imminent delivery for various clients to provincial distribution boards, including the Ontario Cannabis store, the largest distributor of cannabis products in Canada.

Great North Distribution will sell the Tinleys™ products throughout Canada. Great North is Canada's first national sales broker for legalized adult-use cannabis. Established by the owners of Southern Glazer's Wine & Spirits, the world's preeminent distributor for beverage alcohol, Great North Distributors has reach across every province in Canada, with established relationships and expertise in working with Provincially-owned and operated retailers and private retailers alike.

"We're very excited to be selected as the Canadian manufacturing partner for Tinley's carbonated products," said Melise Panetta, President of BevCanna. "Their award-winning products have an exceptional following with consumers internationally, and we're eager to offer them to the Canadian market."

"We're very pleased to be adding another prominent white-label partner to our growing roster of leading brands," continued Ms. Panetta. "We're confident that we'll be able to bring Tinley's to market quickly, while also satisfying the strong demand we're seeing for additional full-service, white-label beverage manufacturing services."

"BevCanna has state of the art equipment that can uniquely accommodate the requirements of our complex formulation methodology and formats," said Ted Zittell, director of Tinley's. "We're excited to bring our products from California back to our home country and are confident these beverages will provide new, unique and compelling cannabis beverage options for Canadian consumers."

Production of "Tinley's™ '27" Cannabis Beverages in Canada

As previously disclosed, the NNCP's have been submitted for all 7 SKU's – the 4 RTD "Tinley'™ Classics" carbonated products (branded Tinley's ™ Tonics in the US) and the 3 "Tinleys™ ‘27" multi-serve products – and the 60-day periods for all 7 SKU's has elapsed without issue. As also disclosed, a Provincial board's formal request to purchase was unable to be fulfilled by the prescribed deadline due to challenges that arose with the Canadian bottle, which differs from the bottles used in California for these products. Over the course of moving manufacturing, additional data reviewed with Tinley's ingredient suppliers and contract manufacturer revealed issues that affect a broad number of cannabis beverages in the industry that employ comparable formulation methods. Tinley has now successfully tested modified formulations and has submitted revised NNCP's for all seven of its products. Tinley does not believe these modifications have any perceptible effect on the products' taste, rapid onset, uplifting Sativa effect or any other element of the product experience. Tinley's original formulations remain compliant and available for sale in California unchanged.

The relevant suppliers intend to use this new intellectual property to make analogous modifications to their various clients' formulations for compliant use in multiple jurisdictions throughout North America. The findings are expected to be published as case study research by the relevant ingredient suppliers. The work constitutes intellectual property that may be used by Tinley's in Canada as well as for its own and co-packing clients' products at its Long Beach facility.

The Company is now taking normal course steps towards commercial production, and endeavors to complete commercial production, pending successful confirmatory testing, at both Peak and BevCanna simultaneous to the 60-day NNCP period. Tinley cautions that Health Canada no longer deems amber bottles or other transparent bottles with most sleeve labels to be compliant; Tinley's therefore intends to source and work with bottles that differ from its California products as well as from previous prototypes of the Canadian products.

The Company's exclusive distributor for infused products, Great North Distributors, has indicated that several of the provincial cannabis boards across the country have given strong indicative interest in carrying Tinley's products, including the two that had made requests for the original products. Modified buying processes at boards across the country, including Ontario, expand the options for completing sales outside of traditional product calls where dispensary demand exists, as is the case for Tinley's products.

About The Tinley Beverage Company and Beckett's Tonics
The Tinley Beverage Company Inc. (OTC:TNYBF, CSE:TNY) manufactures the Beckett's Classics™ and Beckett's 27™ line of non-alcoholic, terpene-infused spirits and cocktails. Beckett's products are available in mainstream food, beverage, and specialty retailers, as well as online, across the United States as well as in grocery and specialty stores in Canada. Cannabis-infused versions of these products are offered under the Tinley's™ brand in licensed dispensaries and home delivery services throughout California, with expansion to Canada underway. Tinley's facility in Long Beach California contains some of the state's most versatile and technologically advanced cannabis-licensed beverage manufacturing equipment and provides manufacturing services for third-party brands in addition to Company-owned brands. Please visit www.drinkbecketts.com, www.drinktinley.com, Twitter and Instagram (@drinktinleys and @drinkbecketts) for recipes, product information and home delivery options.

About BevCanna Enterprises Inc.
BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) is a diversified health & wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna's extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands.

Forward-Looking Statements
This news release contains forward-looking statements and information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws. Forward-looking statements are statements and information that are not historical facts but instead include financial projections and estimates, statements regarding plans, goals, objectives, intentions and expectations with respect to the future business, operations, expansion to additional jurisdictions, , and phrases containing words such as "ongoing", "estimates", "expects", or the negative thereof or any other variations thereon or comparable terminology referring to future events or results, or that events or conditions "will", "may", "could", or "should" occur or be achieved, or comparable terminology referring to future events or results. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, political risks, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects and the other risks involved in the mineral exploration and development industry. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

Products, formulations, and timelines outlined herein are subject to change at any time.

For further information, please contact:

The Tinley Beverage Company
Ted Zittell
(310) 507-9146
info@drinktinley.com
Twitter: @drinktinleys and @drinkbecketts
Instagram: @drinktinleys and @drinkbecketts
www.drinktinley.com
OTC:TNYBF CSE:TNY

BevCanna Enterprises Inc.
Bryce Allen
778-766-3744
bryce@BevCanna.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8f4ab2f8-f323-4422-bbdd-c1b47ad4a35b

News Provided by GlobeNewswire via QuoteMedia

cannabis investing cse:bev Cannabis Investing

Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve.

Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among younger users, and cannabis companies are adapting their offerings to meet shifting demand.

Meanwhile, regulatory uncertainty, particularly surrounding the future of the US Farm Bill and state-level restrictions on hemp-derived cannabinoids, continues to challenge the market.

Despite these headwinds, production data and long-term growth forecasts suggest the cannabis industry remains on a promising — albeit turbulent — path. Read on for more on key trends to watch in 2025.

Consumption methods evolving post-legalization

Shifts in consumer behavior are reshaping markets across the board, and the cannabis industry is no exception.

While smoking remains the dominant method of cannabis consumption, a recent report from the Centers for Disease Control and Prevention highlights the growing popularity of edibles, vaping and dabbing.

The report notes that vaping and dabbing are particularly pronounced among younger adults.

A separate study published by the American Medical Association and funded in part by the Canadian Institutes of Health Research also points to how product preferences have changed among Canadian users since legalization in 2018.

The study indicates that while the use of flower, cannabis concentrates, oil, tinctures and topicals has decreased during that time, the use of vape cartridges, edibles and beverages has increased.

Edibles and beverages were legalized in Canada in late 2019, and Truss Beverage was one of the first players to introduce cannabis-infused drinks. Truss was a joint venture formed by Molson Coors Canada (TSX:TPX.A,TSX:TPX.B) and HEXO, a cannabis company that has since been acquired by Tilray Brands (TSX:TLRY,NASDAQ:TLRY).

In early 2020, Tilray launched a lineup of confectionery, wellness products and beverages through its subsidiary, High Park; Canopy Growth (TSX:WEED,NASDAQ:CGC) made a similar move. These companies gradually brought their products to the US as more states legalized cannabis for medical and/or recreational use.

Today, established cannabis brands typically offer edibles and beverages alongside their other products. Organigram Global (TSX:OGI,NASDAQ:OGI) is one of the newest US entrants, with its April acquisition of Collective Project providing immediate access to the US hemp-derived THC beverage market.

Growing awareness of health and wellness, potentially amplified by the pandemic-led adoption of health trackers, appears to be making an impact on the alcoholic beverage market.

A 2023 Gallup poll reveals a two decade decline in alcohol consumption, particularly among younger adults, suggesting a shift towards more health-conscious lifestyles within this demographic.

Craft beer production declined by 4 percent year-on-year in 2024, according to data collected by the Brewers Association. This marked the largest drop in the industry's history, excluding the pandemic. For small, independent craft breweries, 2024 marked the third consecutive year of declining production. A drop in the number of operating small breweries last year provides further evidence of this trend, with 501 closures in 2024 versus 434 openings.

Challenges in the alcohol market extend beyond the brewing industry, with the New York Times recently reporting the closure of a handful of nightclubs facing decreased alcohol sales alongside rising insurance and rent costs.

Meanwhile, cannabis lounges have been popping up across the US for the last several years. As of early 2025, several states had legalized or were in the process of implementing regulations for cannabis consumption lounges.

Hemp market growth despite regulatory uncertainty

The burgeoning hemp industry is another segment of the expanding cannabis market.

The legalization of industrial hemp — defined as cannabis with a THC concentration of 0.3 percent or less — through the 2018 Farm Bill led to initial investment and optimistic projections for CBD wellness products and various industrial applications. The sector’s rapid evolution also brought the rise of hemp-derived intoxicating cannabinoids, creating a market that presented both opportunities and complexities for participants.

However, after an initial boom, a lack of infrastructure and clearly defined regulations for CBD, as well as state-level variations and market oversupply, ultimately contributed to a quick retraction.

2024 was a pivotal year for the US hemp industry, as the hemp-related provisions of the 2018 Farm Bill — originally set to expire in September 2023, but extended to December 31, 2024 — created an urgent need to address critical issues like THC limits and the regulation of novel hemp-derived cannabinoids. A major point of contention was the proposed shift from defining hemp based on Delta-9 THC concentration (0.3 percent or less) to “total THC,” which includes THCA.

This change had the potential to significantly impact farmers and processors, as many hemp varieties that are compliant under the Delta-9 THC rule could exceed the 0.3 percent limit when THCA is included.

Various bills and amendments were proposed in 2024 as part of the Farm Bill discussions, each with different approaches to regulating hemp. Separate regulatory frameworks for industrial hemp and hemp grown for cannabinoids were suggested, and many states took their own action, leading to a patchwork of regulations and even outright bans.

Despite challenges, data from the US Department of Agriculture suggests signs of recovery.

The department's annual National Hemp Report from 2024 points to an 18 percent increase in industrial hemp production value between 2022 and 2023, with output growth seen in specific sectors like floral (18 percent), fiber (133 percent) and seed hemp (414 percent). The 2025 report from the Department of Agriculture indicates further expansion, with notable increases observed in both acreage (up 64 percent from 2023) and value (46 percent).

The 2024 Farm Bill ultimately did not pass, and right now the hemp industry is operating under a temporary extension of the 2018 Farm Bill under the American Relief Act of 2025, signed into law on December 21, 2024.

The 2018 Farm Bill is now set to expire on September 30, 2025.

While analysts for Markets and Markets project that the North American hemp industry will grow at a CAGR of 22.4 percent and ultimately reach a valuation of US$30.24 billion by 2029, the future of the industry will be heavily influenced by the outcome of the ongoing Farm Bill discussions.

US cannabis legalization remains stalled

Although there is clear demand for cannabis products, the now-defunct rescheduling process in the US is likely to continue casting a shadow of uncertainty over the industry's long-term trajectory.

Legal and procedural delays, including allegations of improper conduct and bias within the US Drug Enforcement Administration (DEA), led to hearing cancellations, and the new administration of US President Donald Trump has brought leadership changes to key agencies like the DEA and the Department of Justice.

Terry Cole, who Trump nominated to be DEA administrator on February 11, has a history of opposing cannabis legalization in the country. Similarly, Pam Bondi, Trump’s pick to lead the justice department, staunchly opposed a movement to legalize medical cannabis during her tenure as Florida’s attorney general.

While there have been bipartisan efforts in Congress to end federal cannabis prohibition and establish regulations for eventual legalization, the DEA’s actions and statements indicate a potential stall or reversal of progress.

In addition to that, new research is adding complexity to the debate.

A study published in the American Journal of Psychiatry this past March highlights an association between the use of high-potency cannabis strains and increased risks of psychosis, a factor that may not have been fully considered by the Department of Health and Human Services. As stronger cannabis strains become more widely available, a reassessment of their potential health risks may be required.

Investor takeaway

While the cannabis industry holds promise for growth and innovation, investors must remain acutely aware of the regulatory uncertainties and market volatility that will undoubtedly shape its trajectory in the years to come.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday, February 27, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Tinley's Signs with BevCanna to Produce its Award-Winning Carbonated Tonics in Canada

In this article

Guide to cannabis in Australia: New South Wales

Guide to cannabis in Australia: Victoria

Guide to cannabis in Australia: Queensland

Guide to cannabis in Australia: South Australia

Guide to cannabis in Australia: Western Australia

Guide to cannabis in Australia: Tasmania

Guide to cannabis in Australia: Northern Territory

Guide to cannabis in Australia: Australian Capital Territory

Consumption methods evolving post-legalization

Hemp market growth despite regulatory uncertainty

US cannabis legalization remains stalled

Investor takeaway

1. Botanix Pharmaceuticals (ASX:BOT)

2. Vitura Health (ASX:VIT)

3. IDT Australia (ASX:IDT)

4. Little Green Pharma (ASX:LGP)

5. Neurotech (ASX:NTI)

6. ECS Botanics (ASX:ECS)

7. Cann Group (ASX:CAN)

8. Althea (ASX:AGH)

9. Ecofibre (ASX:EOF)

10. Argent Biopharma (ASX:RGT)

Road to cannabis rescheduling hits another speed bump

Pennsylvania governor proposes legal cannabis market in state budget

Senate committee re-examines the SAFER Banking Act

Aurora, Canopy Growth report earnings

Latest News

Latest Press Releases

Related News

TOP STOCKS